Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Encompass Health ( (EHC) ) has issued an update.
Encompass Health has announced that it does not provide guidance on a GAAP basis due to the unpredictability of certain items outside its control that are not indicative of its ongoing operations. The company has outlined that these items include government settlements, professional fees, and adjustments related to corporate restructurings, among others. For 2025, Encompass Health has provided estimable GAAP measures for interest expense and amortization of debt, which will be included in the reconciliation for Adjusted EBITDA.
The most recent analyst rating on (EHC) stock is a Buy with a $160.00 price target. To see the full list of analyst forecasts on Encompass Health stock, see the EHC Stock Forecast page.
Spark’s Take on EHC Stock
According to Spark, TipRanks’ AI Analyst, EHC is a Outperform.
Encompass Health’s strong financial performance, particularly in revenue and EBITDA growth, is a major positive factor. The technical indicators support a bullish trend, though caution is advised due to potential overbought conditions. Valuation is moderate, and the earnings call provided a positive outlook despite some operational challenges.
To see Spark’s full report on EHC stock, click here.
More about Encompass Health
Average Trading Volume: 859,359
Technical Sentiment Signal: Buy
Current Market Cap: $12.77B
See more data about EHC stock on TipRanks’ Stock Analysis page.